3-(3-BROMO-PHENYL)-2-METHYL-PROPIONIC ACID, 90.0%, 500mg

4-allyl-5-[1-(4-ethylphenoxy)ethyl]-4H-1,2,4-triazole-3-thiol, 95.0%, 1g

2-(1,3-Benzodioxol-5-yloxy)acetohydrazide, 95.0%, 1g

Methyl 3-amino-5-bromo-4-hydroxybenzoate, 97%, 100mg

Balance à plate-forme série IFB Modèles calibrés en usine, 2/5 g, 6 000/15 000 g, IFB 15K2DM

(S)-TERT-BUTYL 2-METHYL-3-OXOPIPERAZINE-1-CARBOXYLATE, 95.0%, 250mg

(S)-2-((tert-Butoxycarbonyl)amino)-3-(3-(trifluoromethyl)phenyl)propanoic acid, 95.0%, 1g

1-(2,6-Dimethoxybenzyl)piperidin-4-one, 95.0%, 1g

2-methylbutanohydrazide, 95.0%, 1g

tert-butyl 3-[(3-ethoxypropyl)amino]propanoate, 95.0%, 2g

5-Amino-1-(4-bromophenyl)-1H-1,2,3-triazole-4-carboxamide, 95.0%, 500mg

2,4-Dibromobenzoic acid, 98.0%, 100g

2-(morpholin-4-ylmethyl)aniline sulfate hydrate, 95.0%, 25g